The Business Research Company’s report on the Artificial Intelligence In Cardiology Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the artificial intelligence in cardiology industry?
The high burden of cardiovascular diseases is expected to propel the growth of artificial intelligence in the cardiology market going forward. Cardiovascular diseases are all diseases that can affect the heart and blood vessels. In cardiology, AI is used to detect cardiovascular diseases by helping with electrocardiogram (ECG) interpretation and helping spot diseases like long QT syndrome and atrial fibrillation. Also, AI can evaluate vast amounts of data from electronic health records, mobile health devices, and imaging data. For instance, in January 2022, according to an article published by the American Heart Association, a US-based nonprofit organization focused on cardiovascular medical research, approximately 19.1 million deaths were attributed to cardiovascular disease globally in 2022. Furthermore, in May 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, the number of people who died from heart disease in the US increased from 659,041 in 2019 to 695,000 in 2021. Therefore, the high burden of cardiovascular diseases worldwide will drive artificial intelligence in cardiology market.
Access Your Free Sample of the Global Artificial Intelligence In Cardiology Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12686&type=smp
What is the estimated market size of the artificial intelligence in cardiology sector by 2029, based on current forecasts?
The artificial intelligence in cardiology market size has grown exponentially in recent years. It will grow from $1.97 billion in 2024 to $2.72 billion in 2025 at a compound annual growth rate (CAGR) of 37.9%. The growth in the historic period can be attributed to increasing cardiovascular disease burden, big data availability, clinical decision support, growing importance of preventive cardiology, shortages in cardiovascular specialists
The artificial intelligence in cardiology market size is expected to see exponential growth in the next few years. It will grow to $10.76 billion in 2029 at a compound annual growth rate (CAGR) of 41.1%. The growth in the forecast period can be attributed to integration with electronic health records, population aging, wearable devices, remote monitoring, global telecardiology adoption, integrated cardiovascular imaging. Major trends in the forecast period include technological innovations in cardiovascular diagnostics, advancements in ai algorithms, new drug development, advancements in medical imaging.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12686&type=smp
#Who are the top players in the artificial intelligence in cardiology market?
Major companies operating in the artificial intelligence in cardiology market include Microsoft Corporation, International Business Machines Corporation, Siemens Healthineers, Koninklijke Philips, Tempus Labs Inc., Ultromics Ltd, Bay Labs, Cleerly Inc., RSIP Vision Ltd., Idoven, Cardiologs Technologies Inc., Viz.ai, Aidoc, Arterys Inc., Zebra Medical Vision, Vista.ai, AliveCor, DiA Imaging Analysis, Eko Health Inc., Cardiomatics, UltraSight, Anumana Inc., Cardiai Inc.
#What are the major trends in the artificial intelligence in cardiology market?
New AI-powered cardiology products are a key trend in the artificial intelligence in cardiology market. Major companies in the artificial intelligence in the cardiology market are focused on developing innovative AI-powered products for cardiology to strengthen their position in the market. For instance, in February 2023, Eko Health, a US-based digital health company, launched a digital stethoscope platform called SENSORA for detecting heart and lung diseases. SENSORA uses the latest advancements in applied machine learning and artificial intelligence to identify structural murmurs, a sign of valvular heart disease. The SENSORATM is combined with a stethoscope, one of the world’s most widely used medical instruments, with the most recent developments in applied machine learning to create cardiovascular disease detection.
Which geography holds the highest artificial intelligence in cardiology market share?
North America was the largest region in the artificial intelligence in cardiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
How do different segments contribute to the overall expansion of the artificial intelligence in cardiology market?
The artificial intelligence in cardiology market covered in this report is segmented –
1) By Component: Hardware, Software Solutions, Services
2) By Application: Cardiac Arrhythmia, Stroke, Ischemic Heart Disease Or Coronary Artery Disease (CAD), Other Applications
3) By End-Use: Lifescience Companies, Healthcare Payers, Healthcare Providers
Subsegments:
1) By Hardware: Imaging Devices, Wearable Devices, Diagnostic Equipment
2) By Software Solutions: Cardiac Imaging Analysis Software, Predictive Analytics Tools, Patient Management Systems, Telemedicine Platforms
3) By Services: Consulting Services, Integration And Implementation Services, Maintenance And Support Services, Training And Education Services
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12686
How is the artificial intelligence in cardiology market defined?
Artificial intelligence in cardiology refers to techniques used to forecast cardiovascular outcomes, detect malignant arrhythmias, and diagnose coronary artery disease non-invasively. Artificial intelligence in cardiology is used for detecting heart disease, treating strokes quickly, and enhancing diagnostic radiology capabilities.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
